Background Gut bacteria have been implicated in a wide range of health conditions, yet their potential role in preventing and treating muscle-wasting disorders remains largely unexplored. Objective We ...

Apitegromab improved motor function in SMA patients in a Phase 3 trial analysis, with stronger benefits seen in those treated earlier.

NMD Pharma will also present an update on the ongoing SYNAPSE-MG Phase 2b clinical trial of ignaseclant in generalized myasthenia gravisAarhus, ...

Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of ...

Adults lose 8% of muscle mass each decade after 30, but experts say current protein recommendations may be too low for ...

GLP-1 drugs like (Ozempic and Wegovy) have finally started to make weight loss a sustainable reality for many people with ...

A 15-year study shows that the drug pergolide is an effective treatment for pituitary pars intermedia dysfunction.

William is a seven-year-old boy from Southern Oregon living with Duchenne muscular dystrophy. Now, he is preparing to undergo a surgery that has never been tried before, a procedure designed ...

Bangkok Hospital Introduces Precision Medicine Hub in Southeast Asia featuring Gene Therapy for Children with Spinal Muscular Atrophy (SMA) & Anti-Amyloid Therapy for Alzheimer's Disease ...

MRI demonstrates psoas and rectus atrophy plus lower trunk and hip strength in chronic low back pain compared with healthy controls. Chronic low back pain remains a leading driver of disability, yet ...

Before Adam Sharples became a molecular physiologist studying muscle memory, he played professional rugby. Over his years as an athlete, he noticed that he and his teammates seemed to return to form ...